Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Norway
/
Food, Beverage & Tobacco
Create a narrative
Aker BioMarine
OB:AKBM Community
Create a narrative
Aker BioMarine
Undervalued
Overvalued
Aker BioMarine
WA
Analyst Price Target
Consensus Narrative from 2 Analysts
Partnerships In Japan And China Will Expand Kori Brand's International Reach
Key Takeaways Divesting Understory should streamline operations and enhance net margins, as the company refocuses on core segments like Human Health Ingredients. Expansion in Asia and optimizing production processes suggest potential revenue growth and improved operating margins through strategic partnerships and cost reductions.
View narrative
NOK 60.69
FV
4.6% overvalued
intrinsic discount
-9.80%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Your Valuation for
AKBM
Aker BioMarine
Your Fair Value
NOK
Current Price
NOK 63.50
64.5% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-34m
335m
2015
2018
2021
2024
2025
2027
2030
Revenue US$268.7m
Earnings US$2.1m
Advanced
Set as Fair Value